StonvexLoading…
StonvexStonvexStonvexCore line items from AMTB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $133.02M | $597.43M | $450.25M | $297.50M |
Operating Income | $22.94M | $66.14M | $64.23M | $45.23M |
Net Income | $17.87M | $52.42M | $49.72M | $23.00M |
EPS (Diluted) | $0.44 | $1.26 | $1.19 | $0.83 |
Total Assets | $9.90B | $9.78B | $10.41B | $10.33B |
Total Liabilities | $8.99B | $8.84B | $9.47B | $9.41B |
Cash & Equivalents | $188.71M | $470.15M | $630.86M | $636.84M |
Free Cash Flow OCF − CapEx | $10.15M | $129.24M | $97.96M | $74.25M |
Shares Outstanding | 39.80M | 40.60M | 41.94M | 42.03M |